共 50 条
- [42] Characterization of CCX282-B, an Orally Bioavailable Antagonist of the CCR9 Chemokine Receptor, for Treatment of Inflammatory Bowel Disease JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2010, 335 (01): : 61 - 69
- [45] STUDIES OF NATURAL LIGANDS OF CHEMOKINE RECEPTOR CCR6 ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2002, 58 : C281 - C281
- [46] Antagonists of chemokine receptor CCR9 synergize with anti-TNFα immunotherapy to reduce inflammation in the MDR1a-/- mouse model of colitis JOURNAL OF IMMUNOLOGY, 2020, 204 (01):
- [48] Antagonism of chemokine receptor CCR9 synergises with anti-TNFα immunotherapy to reduce inflammation in the MDR1a-/- mouse model of colitis JOURNAL OF CROHNS & COLITIS, 2020, 14 : S150 - S150
- [49] CCR9A and CCR9B:: Two receptors for the chemokine CCL25/TECK/Ckβ-15 that differ in their sensitivities to ligand JOURNAL OF IMMUNOLOGY, 2000, 164 (03): : 1293 - 1305
- [50] Cutting edge: Identification of a novel chemokine receptor that binds dendritic cell- and T cell-active chemokines including ELC, SLC, and TECK JOURNAL OF IMMUNOLOGY, 2000, 164 (06): : 2851 - 2856